167 related articles for article (PubMed ID: 35267605)
1. Prognosis and Sensitivity of Adjuvant Chemotherapy in Mucinous Colorectal Adenocarcinoma without Distant Metastasis.
Bong JW; Gim JA; Ju Y; Cheong C; Lee SI; Oh SC; Min BW; Kang S
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267605
[TBL] [Abstract][Full Text] [Related]
2. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China.
Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J
Front Oncol; 2024; 14():1335678. PubMed ID: 38380362
[TBL] [Abstract][Full Text] [Related]
4. Mucinous histology is associated with poor prognosis in locally advanced colorectal adenocarcinoma treated with postoperative first-line adjuvant chemotherapy: A systematic review and meta-analysis.
Zhang Y; Chen Y; Huang J; Wu X; Tang R; Huang Q; Xu Y; Peng X; Fu K; Xiao S
Eur J Surg Oncol; 2022 Oct; 48(10):2075-2081. PubMed ID: 35768312
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study.
Yan C; Yang H; Chen L; Liu R; Shang W; Yuan W; Yang F; Sun Q; Xia L
BMC Cancer; 2021 Dec; 21(1):1286. PubMed ID: 34852768
[TBL] [Abstract][Full Text] [Related]
6. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.
Nitsche U; Zimmermann A; Späth C; Müller T; Maak M; Schuster T; Slotta-Huspenina J; Käser SA; Michalski CW; Janssen KP; Friess H; Rosenberg R; Bader FG
Ann Surg; 2013 Nov; 258(5):775-82; discussion 782-3. PubMed ID: 23989057
[TBL] [Abstract][Full Text] [Related]
7. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Lymph Node Metastasis and Prognosis in pT1 Colorectal Cancer Patients with Signet-Ring Cell and Mucinous Adenocarcinomas.
Song BR; Xiao CC; Wu ZK
Cell Physiol Biochem; 2017; 41(5):1753-1765. PubMed ID: 28365687
[TBL] [Abstract][Full Text] [Related]
9. The prognostic relevance of histologic subtype in appendiceal adenocarcinoma.
Legué LM; van Erning FN; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Eur J Surg Oncol; 2020 Mar; 46(3):433-438. PubMed ID: 31668980
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.
Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK; Yang SH
Front Oncol; 2021; 11():620146. PubMed ID: 33738258
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of three histological subtypes of colorectal adenocarcinoma: A retrospective analysis of 8005 Chinese patients.
Li C; Zheng H; Jia H; Huang D; Gu W; Cai S; Zhu J
Cancer Med; 2019 Jul; 8(7):3411-3419. PubMed ID: 31074597
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
[TBL] [Abstract][Full Text] [Related]
14. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis.
Verhulst J; Ferdinande L; Demetter P; Ceelen W
J Clin Pathol; 2012 May; 65(5):381-8. PubMed ID: 22259177
[TBL] [Abstract][Full Text] [Related]
15. Inverse effect of mucinous component on survival in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells.
Kong X; Zhang X; Huang Y; Tang L; Peng Q; Li J
Cancer Manag Res; 2017; 9():573-580. PubMed ID: 29138597
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis.
Li C; Su D; Peng J; Fang Y; Zhou W; Li S; Luo B; Wan D; Pan Z
Ann Palliat Med; 2019 Nov; 8(5):690-697. PubMed ID: 31735042
[TBL] [Abstract][Full Text] [Related]
18. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.
Kanda M; Oba K; Aoyama T; Kashiwabara K; Mayanagi S; Maeda H; Honda M; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T;
Dis Colon Rectum; 2018 Apr; 61(4):461-471. PubMed ID: 29521828
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Recurrence of Radically Resected Mucinous Colorectal Adenocarcinoma.
Huang Q; Zou MH; Wei JC; Jiang Y; Chen ZP; Wang Q; Li WL; Cao J
Cancer Manag Res; 2021; 13():4777-4790. PubMed ID: 34168497
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
